Stay updated on SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial
Sign up to get notified when there's something new on the SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial page.

Latest updates to the SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check26 days agoChange DetectedA banner announces that NIH is transitioning to the term “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), and directs visitors to updates and FAQs.SummaryDifference0.8%

- Check33 days agoChange DetectedThe footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check40 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check61 days agoChange DetectedNew revision entry v3.7.0 has been added to the study record history, and the previous revision v3.6.6 has been removed from the history.SummaryDifference0.1%

- Check82 days agoChange DetectedA new revision entry v3.6.6 was added to the record history and the previous entry v3.6.5 was removed.SummaryDifference0.1%

Stay in the know with updates to SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial page.